1) microvessel density(MVD)
微血管密度(MVD)
1.
Methods:To detect expression of CD24 and VEGF in 120 specimens(80 transurethral resection,40 radical cystectomy) of bladder urothelial carcinoma and 10 specimens normal bladder tissues by SP immunohistochemistry, Microvessel density(MVD) was figured out according to the positive staining for VEGF.
方法:采用免疫组织化学SP法检测了120例(80例经尿道切除标本,40例根治性膀胱切除标本)膀胱尿路上皮癌组织中CD24、VEGF的表达,根据VEGF的染色情况计算出膀胱尿路上皮癌组织的微血管密度(MVD)。
2.
Methods The expression of midkine protein levels and microvessel density(MVD)were detected by immunohistochemical technique(S-P)in 52 meningioma tissues and 10 human normal cerebral maters.
方法采用S-P免疫组织化学技术,检测52例脑膜瘤组织和10例正常脑膜组织中MK蛋白的表达和微血管密度(MVD),并对二者的关系进行统计学分析。
2) MVD
微血管密度(MVD)
1.
The Expression of PD-ECGF, bFGF in Colorectal Cancer and Their Relationship with Microvessel Density(MVD);
血小板衍化内皮细胞生长因子（PD-ECGF）、碱性成纤维细胞生长因子（bFGF）在结直肠癌中的表达及与微血管密度（MVD）的关系
2.
The Expression of HIF-1a、VEGF in Gastric Carcinoma and Their Relationship with Microvessel Density(MVD);
缺氧诱导因子（HIF）-1α、血管内皮生长因子（VEGF）在胃癌中的表达及与微血管密度（MVD）的关系
3.
Methods The expression of HPA、PCNA LI、MVD and AI in 69 cases of gliomas and 8 cases of normal brain tissues were comparatively studied with immunohistochemical staining method and TUNEL.
方法采用免疫组织化学方法和TUNEL法分别检测69例胶质瘤和8例正常脑组织中HPA蛋白表达、PCNA标记指数(PCNA LI)、微血管密度(MVD)和瘤细胞的凋亡指数(AI)。
3) microvessel density (MVD)
微血管密度(MVD)
4) microvessel density
微血管密度(MVD)
1.
【Objective】To investigate their relations of the expressions of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial cell growth factor (VEGF) and microvessel density (MVD) with the angiogenesis and the biological behaviour characteristics in transitional cell carcinoma of the bladder (TCCB).
目的研究膀胱癌及正常膀胱组织缺氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)的表达及微血管密度(MVD)在膀胱移行细胞癌血管生成及生物学行为的关系。
5) micro vessel density
微血管密度(MVD)
1.
The ectopic focus volume and histomorphology were observed,and the vescularendothelial growth factor(VEGF) and micro vessel density(MVD) were observed in ectopic endometrium by immunohistochemistry(S-P technique).
方法:建立Wistar大鼠子宫内膜异位症动物模型,4周后将成模大鼠随机分为对照组、腹腔注射5-氟尿嘧啶30mg/kg组、5-氟尿嘧啶20mg/kg组、5-氟尿嘧啶10mg/kg组,各2周,观察各组异位病灶在给药前后体积及形态的变化,免疫组化法测定异位组织微血管密度(MVD)值和血管内皮生长因子(VEGF)的表达。
2.
Objective:To explore the mechanism and evaluate Artesunate\'s effect on endometriosis and angiogenesis by detecting ectopic endometrium volume,VEGF expression and micro vessel density(MVD)in ectopic endometrium of model rats.
d,采用灌胃法连续给药15d,观察各组异位子宫内膜体积,免疫组化法测定血管内皮生长因子(VEGF)的表达,并通过CD34标记异位子宫内膜血管,测定其微血管密度(MVD)。
6) Microvascular density
微血管密度(MVD)
1.
Methods The expression of Epo-R and microvascular density(MVD) were detected by immunohistochemistry for 41 patients with breast cancer.
方法应用免疫组化方法检测41例乳腺癌患者的Epo-R的表达,同时检测肿瘤微血管密度(MVD),并分析与临床病理之间的关系。
补充资料：CO2微泡超声血管造影
CO2微泡超声血管造影
影像学术语。利用CO2微泡作为声学对比剂施行的超声血管成像方法。利用两个注射器与三通管连接，将10ml CO2、10ml肝素化生理盐水及5ml病人自身血液充分混匀制成CO2微泡。常规肝动脉造影后经置于肝固有动脉(或左、右分支)内的导管，以2ml/s的速度缓慢注入CO2微泡。根据CO2微泡在肝实质内充盈程度分为早、中、晚三期。CO2微泡开始充盈肝实质为早期，历时5～10s；CO2微泡持续充盈肝实质为中期，约10～60s；完全从肝实质内清除为晚期，相当于注入CO2微泡后的1～7分钟。此方法的所见与血管造影静脉期相似，但发现小病灶优于血管造影。CO2-Dus对血管造影不能显示的等血管性或少血管性肝细胞癌有价值。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条